CagriSema dosage and reconstitution
Semaglutide plus the amylin peptide cagrilintide in one weekly shot. More weight loss than either alone in phase 3; not yet approved.
Staying safe
Things people sometimes notice
- Nausea in the first days after each step up, usually worse than semaglutide alone
- Feeling full after a few bites
- Constipation, or the opposite
- Tiredness and mild headache in the first two weeks
Stop and get help if (trouble breathing or swelling: call 911)
- Vomiting you cannot keep fluids down through, or signs of dehydration (dark urine, dizziness)
- Severe stomach pain that goes through to your back (possible pancreatitis)
- A lump in the neck, hoarseness or trouble swallowing
- Hives, swelling or trouble breathing
Talk to your doctor first, especially if
- You have had pancreatitis or gallstones; both are known risks of the GLP-1 class
- You or a close relative had medullary thyroid cancer or MEN 2; the GLP-1 class carries a boxed warning for this
- You take insulin or a sulfonylurea; combined glucose lowering can cause hypoglycemia and doses usually need cutting
- You are pregnant, nursing or planning pregnancy; stop two months before trying
Mixing it
CagriSema is designed as a finished once-weekly injection with a titration schedule similar to Wegovy, starting low and stepping up over several months. It is Novo's dual-chamber clinical product, not a reconstitute-it-yourself powder, and final approved dosing will be set by regulators.
Start at the low titration dose to let the gut adjust.
Step up gradually over several months per the schedule.
Inject subcutaneously once a week on the same day.
Eat smaller, slower meals to ease nausea.
Stay hydrated and follow your prescriber's dosing if it becomes available.